drugset / Trial / NCT03528577
A Study to Evaluate the Effect of of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg Base (Sun Pharmaceuticals Industries Limited)
RandomizedCrossoverQuadruple-blindTreatment
Summary
To Evaluate the Pharmacodynamic Equivalence of Albuterol Sulfate Inhalation Aerosol, eq 90 mcg base (Sun Pharmaceuticals Industries Limited) to PROAIR® HFA (albuterol sulfate) Inhalation Aerosol, eq 90 mcg base (Teva Respiratory, LLC) in Subjects With Stable, Mild Asthma
Timeline
- Start
- 2018-09-22
- Primary completion
- 2019-03-11
- Completion
- 2019-08-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Salbutamol | Unknown | 90 ug | Inhaled |
| Subject | Salbutamol | Unknown | 180 ug | Inhaled |